Deregulation of the p53 pathway causes its contribution to nearly half of human cancers in pathogenesis, including ovarian, colon and rectal, lung, pancreatic, stomach, urethral, liver, breast, and prostate cancers (Wang et al. 2023; Zhou et al. 2019). This evidence concerns the gene TP53 and cancer.